Stephen Dobratz, MD
Interventional Cardiology · Russellville, ARNPI 1023011194
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (56.5%), travel and lodging and education — rather than concentrated in one kind of arrangement. 21 manufacturers reported payments, led by Medtronic at 49.7% of the total. Reporting peaked in 2019 at $4,497 and has fallen 87.0% since, to $584 in 2025.
Across 169 payments — averaging $56.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$5K
- Abiomed$3K
- Cardiovascular Systems Inc.$610
- Philips North America LLC$427
- Astellas Pharma US Inc$198
- Shockwave Medical, Inc$187
- plus $809 from 15 others
What the payments were for
- Travel & lodging$3,97841%
- Food & beverage$5,42056%
- Education$1982%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 88 | $4,769 |
| Abiomed | 16 | $2,597 |
| Cardiovascular Systems Inc. | 5 | $610 |
| Philips North America LLC | 10 | $427 |
| Astellas Pharma US Inc | 2 | $198 |
| Shockwave Medical, Inc | 1 | $187 |
| Abbott | 5 | $144 |
| Novartis | 14 | $140 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 12 | $139 |
| Imperative Care, Inc | 2 | $79 |
| Boston Scientific | 4 | $75 |
| Silk Road Medical, Inc. | 1 | $65 |
| Livanova USA, Inc. | 1 | $25 |
| Kestra Medical Technology Services, Inc. | 1 | $21 |
| Cagent Vascular Inc | 1 | $20 |
| Bardy Diagnostics, Inc. | 1 | $20 |
| Amgen | 1 | $20 |
| Lantheus Medical Imaging, Inc. | 1 | $18 |
| Irhythm Technologies, Inc. | 1 | $15 |
| AstraZeneca | 1 | $15 |
| Sanofi-aventis U.S. LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,596 in reported general payments places this provider in the 65th percentile of 89 interventional cardiology providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 18 | $138 |
| Metoprolol Succinate | 13 | $130 |
| Atenolol | 13 | $47 |
| Amlodipine Besylate | 21 | $34 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Russellville
- Sabeeda KadavathRussellville$8K
- Zoltan VargaRussellville$6K
- Gaurav DharLittle Rock$206K
- Ernesto Ruiz-RodriguezLittle Rock$153K
- Vasili LendelLittle Rock$86K
- Thomas WattsLittle Rock$68K
- Vijay RajaLittle Rock$46K
- Lena AwarJonesboro$43K
- Zubair AhmedFayetteville$36K
- Stephen BroughtonLittle Rock$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.